These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9852410)

  • 1. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
    de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
    Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and recovery of apheresis platelets stored in a polyolefin container with high oxygen permeability.
    Ezuki S; Kanno T; Ohto H; Herschel L; Ito T; Kawabata K; Seino O; Ikeda K; Nollet KE
    Vox Sang; 2008 May; 94(4):292-8. PubMed ID: 18331381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
    Sandgren P; Hansson M; Gulliksson H; Shanwell A
    Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
    Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
    Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution.
    Sweeney J; Kouttab N; Holme S; Kurtis J; Cheves T; Nelson E
    Transfusion; 2006 May; 46(5):835-40. PubMed ID: 16686852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Properties of stored platelet concentrates: effect of the suspension media and type of pouch used].
    Castrillo A; Castro A; Cid J; Adelantado M; Eiras A; Flores J; Solla E; Varela J; García-Villaescusa R
    Sangre (Barc); 1999 Oct; 44(5):315-8. PubMed ID: 10618906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of platelet storage conditions by using new polyolefin containers.
    de Wildt-Eggen J; Schrijver JG; Bouter-Valk HJ; Fijnheer R; Bins M; van Prooijen HC
    Transfusion; 1997 May; 37(5):476-81. PubMed ID: 9149770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates.
    Zhang JG; Carter CJ; Devine DV; Scammell K; Weiss S; Gyongyossy-Issa MI
    Vox Sang; 2008 May; 94(4):299-305. PubMed ID: 18179681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and storage of white blood cell-reduced split apheresis platelet concentrates for pediatric use.
    van der Meer PF; Vrielink H; Pietersz RN
    Transfusion; 2005 Feb; 45(2):223-7. PubMed ID: 15660831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.
    Cid J; Magnano L; Molina P; Diaz-Ricart M; Martínez N; Maymó RM; Puig L; Lozano M; Escolar G; Galán AM
    Transfusion; 2014 Feb; 54(2):426-33. PubMed ID: 23721299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
    van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
    Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.
    van der Meer PF; Pietersz RN; Reesink HW
    Transfusion; 2004 Aug; 44(8):1204-11. PubMed ID: 15265125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
    Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
    Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet additive solutions: a future perspective.
    van der Meer PF
    Transfus Clin Biol; 2007 Dec; 14(6):522-5. PubMed ID: 18420439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved extension of platelet storage in a polyolefin container with higher oxygen permeability.
    Yuasa T; Ohto H; Yasunaga R; Kai T; Shirahama N; Ogata T
    Br J Haematol; 2004 Jul; 126(1):153-9. PubMed ID: 15198746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.